MassDevice

Johnson & Johnson MedTech submits Ottava surgical robot to FDA

Johnson & Johnson MedTech announced today that it submitted its Ottava surgical robotic system to the FDA for de novo ...
Morningstar

Aqua Medical Secures FDA IDE to Study its Breakthrough Endoscopic Technology for the treatment of Type 2 Diabetes

PLEASANTON, Calif., Nov. 4, 2025 /PRNewswire/ -- Aqua Medical, a company advancing Endoscopic Metabolic Restoration for type 2 diabetes, today announced that the U.S. Food and Drug Administration (FDA ...
Morningstar

EyeYon Medical Ltd. Receives FDA IDE Approval to Initiate U.S. Clinical Study of EndoArt®, the First Artificial Endothelial Layer for Corneal Edema

NES ZIONA, Israel, Dec. 8, 2025 /PRNewswire/ -- EyeYon Medical Ltd., a global leader in ophthalmic innovation, today announced that the U.S. Food and Drug Administration (FDA) has granted ...
Joplin Globe

Pulse Biosciences Announces FDA IDE Approval to Initiate its nPulse Cardiac Catheter Ablation System Study for the Treatment of Atrial Fibrillation

Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel nPulse™ technology using its proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced ...
BioWorld

Onward Medical receives FDA IDE for BP study with ARC-IM system

Onward Medical NV secured U.S. FDA investigational device exemption (IDE) approval for a pivotal study to assess the safety and efficacy of its implantable spinal stimulation technology, the ARC-IM ...
MarketWatch

Aqua Medical Secures FDA IDE to Study its Breakthrough Endoscopic Technology for the treatment of Type 2 Diabetes

The MarketWatch News Department was not involved in the creation of this content. PLEASANTON, Calif., Nov. 4, 2025 /PRNewswire/ -- Aqua Medical, a company advancing Endoscopic Metabolic Restoration ...